==notable?–
>>8306939 UPS worker who threatened mass shooting had body armor, tactical rifles, 20,000 rounds ammo (Sunnyvale, CA)
notable
>>8306939 UPS worker who threatened mass shooting had body armor, tactical rifles, 20,000 rounds ammo (Sunnyvale, CA)
Sorry muh redtext fail
Honeywell was acquired by General Electric
General Electric Company. In October 2000, Honeywell (then valued at over $21 billion) accepted a takeover bid from then-CEO Jack Welch of General Electric. The American Department of Justice cleared the merger, while "GE teams swooped down on Honeywell" and "GE executives took over budget planning and employee reviews."
POTUS tweeted about GE CEO Jack Welch's death yesterday.
I think we need to review US patent law related to biological materials. Let's start from Wikipedia.
https://en.wikipedia.org/wiki/Biological_patents_in_the_United_States
Biological patents in the United States
As with all utility patents in the United States, a biological patent provides the patent holder with the right to exclude others from making, using, selling, or importing the claimed invention or discovery in biology for a limited period of time - for patents filed after 1998, 20 years from the filing date.[1]
Until recently, natural biological substances themselves could be patented (apart from any associated process or usage) in the United States if they were sufficiently "isolated" from their naturally occurring states. Prominent historical examples of such patents on isolated products of nature include adrenaline, insulin, vitamin B12, and gene patents. However, the US Supreme Court ruled in 2013 that mere isolation by itself is not sufficient for something to be deemed inventive subject matter.[2]
The United States has been patenting chemical compositions based upon human products for over 100 years. The first patent for a human product was granted on March 20, 1906, for a purified form of adrenaline. It was challenged and upheld in Parke-Davis v. Mulford.[3] Judge Hand argued that natural substances when they are purified are more useful than the original natural substances.[4]
The 1970s marked the first time when scientists patented methods on their biotechnological inventions with recombinant DNA. It wasn’t until 1980 that patents for whole-scale living organisms were permitted. In 1980, the U.S. Supreme Court, in Diamond v. Chakrabarty, upheld the first patent on a newly created living organism, a bacterium for digesting crude oil in oil spills. The patent examiner for the United States Patent and Trademark Office had rejected the patent of a living organism, but Chakrabarty appealed. As a rule, raw natural material is generally rejected for patent approval by the USPTO. The Court ruled that as long as the organism is truly "man-made," such as through genetic engineering, then it is patentable. Because the DNA of Chakrabarty's organism was modified, it was patentable.
Since that 1980 court case, there have been many patents of genetically modified organisms. This includes bacteria (as just mentioned), viruses, seeds, plants, cells, and even non-human animals. Isolated and manipulated cells - even human cells - can also be patented. In 1998, the U.S. Patent and Trademark Office (PTO) issued a broad patent claiming primate (including human) embryonic stem cells, entitled "Primate Embryonic Stem Cells" (US 5843780). On 13 March 2001, a second patent (US 6200806) was issued with the same title but focused on human embryonic stem cells. In another example, a genetically modified mouse, dubbed the Oncomouse, that is useful for studying cancer, was patented by Harvard University as US 4736866.
Companies and organizations, like the University of California, have patented entire genomes.
An early example of a food patent is the patent granted to RiceTec for basmati rice in 1997.[6] In 1999, a patent was filed for a peanut butter and jelly sandwich that was without crust.[7] Agriculture giant Monsanto filed for a patent on certain pig genes in 2004.[8]
Gene patents
A gene patent is a patent on a specific isolated gene sequence, its chemical composition, the processes for obtaining or using it, or a combination of such claims. With respect to subject matter, gene patents may be considered a subset of the broader category of biological patents.
Gene patents may claim the isolated natural sequences of genes, the use of a natural sequence for purposes such as diagnostic testing, or a natural sequence that has been altered by adding a promoter or other changes to make it more useful. In the United States, patents on genes have only been granted on isolated gene sequences with known functions, and these patents cannot be applied to the naturally occurring genes in humans or any other naturally occurring organism.
…
The "Chakrabarty patent", owned by General Electric, was filed in 1972 and issued in 1981 after the Supreme Court decision discussed above.[10][11] While not commercially important,[10] this patent and the Supreme Court case "opened the floodgates for protection of biotechnology-related inventions and helped spark the growth of an industry."
How to report something to the BO.
Go to the item to be reported.
(Click it, open it for viewing).
Clicky little triangle on left side of the item.
Select REPORT.
Fill out the report form with 1-line description/request.
Submit.
That's the ONLY WAY to get BO's attention.
Out of band notification is the best way to get their attention.
Do you personally read every single post? Is it even humanly feasible? I'm one of the anons who is here practically all the time, and admittedly I do not read every single post.
I almost never click the catalog. A few times a week maybe. Anons have another ways to navigate.
I'm not for or against your concern with BO. I'm just speaking of technical matters.